28
Oct
2025

Polpharma S.A.

Exhibitor at CPHI Frankfurt 2025 stand 9.1B74, Integrated Pharma
About Us

Polpharma Group. European business partner for pharmaceutical companies worldwide. Diversified business oportunities - API, CDMO, OL, In-licensing - supported by professional services and competencies dedicated to the B2B partners to grow beyond the scale together. We are offering environment for collaboration, support from qualified experts and state-of-the-art facilities. We are actively looking for partners in all of our activity areas – from product development stage, through production and commercial cooperation, to other forms of partnership.

Polpharma API. Eu...

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • PL
  • 2015
    On CPHI since
  • 4
    Certificates
  • 5000+
    Employees
Company types
CMO/CDMO
Contract Service
Generics/Biosimilars Manufacturer
Manufacturer/Innovator
Pharmaceutical company
View company profile
Contact info
Show contact info Hide contact info
Event information
CPHI Frankfurt 2025
  • 28 Oct 2025 - 30 Oct 2025
  • Messe, Frankfurt
  • Visit us at stand 9.1B74, Integrated Pharma

Products Featured at CPHI Frankfurt 2025

  • Acenocoumarol

    Product Acenocoumarol

    Therapeutic Area: Cardiovascular systemEU DMF available Indication: Acenocoumarol is an anticoagulant that functions as a vitamin K antagonist
  • Acetazolamide

    Product Acetazolamide

    Therapeutic Area: Cardiovascular systemEU DMF availableUS DMF no. 10383 availableCEP available Available also in injectable form Indication: Acetazolamide decreases the pressure in the eye and is used for adjunctive treatment of glaucoma, a condition in which increased pressure in the eye can lead to ...
  • Aripiprazole

    Product Aripiprazole

    Therapeutic Area: Nervous SystemEU DMF availableUS DMF no. 23314 availableCEP available Indication: used to treat the symptoms of psychotic conditions such as schizophrenia and bipolar disorder (manic depression). It is also used together with other medications to treat major depressive disorder in adult...
  • Carbamazepine

    Product Carbamazepine

    Therapeutic Area: Nervous System EU DMF availableUS DMF no. 26266 availableCEP available Indication: Carbamazepine is an anticonvulsant and mood-stabilizing drug used primarily in the treatment of epilepsy and bipolar disorder, as well as trigeminal neuralgia.
  • Carvedilol

    Product Carvedilol

    Therapeutic Area: Cardiovascular systemEU DMF availableUS DMF no. 17060 availableCEP available Indication: Carvedilol is a carbazole derivative acts as anti-hypertensive agent. It is formulated as tablets for oral route of administration. Carvedilol is indicated for the management of essential hypertens...
  • Carvedilol phosphate hemihydrate

    Product Carvedilol phosphate hemihydrate

    Therapeutic area: Cardiovascular systemEU DMF availableUS DMF no. 20633 available
  • Clopamide

    Product Clopamide

    Therapeutic Area: Cardiovascular systemEU DMF available Indication: Clopamide is indicated for the treatment of oedema, hypertension. It is formulated as tablet for oral administration. It is categorised as a thiazide like drug and works in similar way as the thiazide diuretics. It acts at the proximal c...
  • Etodolac

    Product Etodolac

    Therapeutic Area: Musculo-skeletal systemEU DMF availableUS DMF no. 11405 availableJapanese DMF availableCEP available Indication: Etodolac is a nonsteroidal anti-inflammatory drug (NSAID) used for the management of mild to moderate pain, fever, and inflammation.
  • Tadalafil

    Product Tadalafil

    Therapeutic area: genito-urinary system & sex hormones EU DMF available US DMF : 24590 CEP available
  • Ticagrelor

    Product Ticagrelor

    Ticagrelor 

    form II 

    Own process patent to free from nitrosamines 

    CEP, 
    US DMF, 
    EU DMF,  
    Korean DMF, 
    Canadian DMF, 
    Cadifa

    DISCLAIMER

    Products protected b...
  • Hydrochlorothiazide

    Product Hydrochlorothiazide

    Hydrochlorothiazide

    Therapeutic Area: Cardiovascular system • EU DMF available • US DMF no. 17599 available • Japanese DMF available  • CEP available  
    DISCLAIMER

    Products protected by valid patents are not offered for sale in countries where the sale of ...
  • Alendronate sodium

    Product Alendronate sodium

    Alendronate Sodium
    Trihydrate

    > No risk of presence of nitrosamines
    > Long experience with commercial manufacturing
    > In-house production of the whole product family (Risedronate, Alendronate, Ibandronate)

    CEP, 
    US D...
  • Pentoxifylline

    Product Pentoxifylline

    Pentoxifylline
    Form I

    > Very long production experience
    > Tailor made PSD

    CEP, 
    US DMF, 
    CHINESE


    This product is not offered for sale or made available in countries where it is subject to patent (SP...
  • Dapagliflozin

    Product Dapagliflozin

    Dapagliflozin
    amorphous & propanediol

    > Cryogenic process
    > Green Chemistry

    EU DMF
    US DMF
    Korean DMF
    Canadian DMF 
    DISCLAIMER

    Products protected by valid patents are not offer...
  • Enzaluthamide

    Product Enzaluthamide

    Enzalutamide 
    Anhydrous form R1 

    CAS No: 915087-33-1
    DISCLAIMER

    Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes patent infringement. It is within the buyer’s respon...
  • Palbociclib

    Product Palbociclib

    Palbocyclib

    CRYSTAL FORM A
    US DMF pending

    DISCLAIMER

    Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes patent infringement. It is within the buyer’s responsibility and liab...
  • Apixaban

    Product Apixaban

    Apixaban

    Polymorphic form N-1

    > No risk of nitrosamines > Eco friendly process
    > PSD flexibility via micronization

    EU DMF, 
    US DMF, 
    KOREAN DMF
    DISCLAIMER

    Products protected by va...
  • Empagliflozin

    Product Empagliflozin

    Empagliflozin

    CRYSTALLINE ANHYDROUS

    > Cryogenic process
    > Green chemistry

    EU DMF, 
    US DMF, 
    CHINESE DMF, 
    KOREAN DMF

    DISCLAIMER

    Products protected by valid patents...
  • Baclofen

    Product Baclofen

    Baclofen
    FORM B

    Own innovative process

    Global market leader
    CEP, US 
    DMF, 
    JAPANESE DMF, 
    KOREAN DMF, 
    CANADIAN DMF

    DISCLAIMER

    Products protected by valid patents are not offered for s...
  • Rivaroxaban

    Product Rivaroxaban

    Rivaroxaban

    MODIFICATION I

    > No risk of presence of nitrosamines
    > Innovative crystalization obtaining material of high purity

    CEP, 
    US DMF, 
    CHINESE DMF, 
    KOREAN DMF 
    DISCLAIMER ...
  • Trametinib

    Product Trametinib

    Trametinib

    DMSO solvate

    Oncology

    OEB 5
    DISCLAIMER

    Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes patent infringement. It is within the buyer’s responsibility and liability...
  • Zoledronic Acid

    Product Zoledronic Acid

    Zoledronic Acid

    Monohydrate

    > No risk of presence of nitrosamines
    > Long experience with commercial manufacturing
    > In-house production of the whole product family (Risedronate, Alendronate, Ibandronate)

    ...
  • Piracetam

    Product Piracetam

    Piracetam
    Form II

    > Capacity and flexibility to cover high-volume demand
    oral & injectable forms

    CEP, 
    BRAZILIAN DMF"

    DISCLAIMER

    Products protected by valid patents are not offered for sale in cou...
  • Linagliptin

    Product Linagliptin

    Linagliptin

    Mix A&B

    > White API color
    > Better impurity profile


    DISCLAIMER

    Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes patent infringement. It ...
  • Elagolix sodium Amorphous form

    Product Elagolix sodium Amorphous form

    DISCLAIMER

    The above product is presented solely for informational purposes and does not constitute an offer in any sense. Products with PIPELINE & EARLY DEVELOPMENT STATUS under patent (SPC) protection in Poland and/or other countries are not offered until expiration of the corresponding IP...
  • Empagliflozin Crystalline anhydrous

    Product Empagliflozin Crystalline anhydrous

    DISCLAIMER

    The above product is presented solely for informational purposes and does not constitute an offer in any sense. Products with PIPELINE & EARLY DEVELOPMENT STATUS under patent (SPC) protection in Poland and/or other countries are not offered until expiration of the corresponding IP...
  • Linagliptin Mix of form A & B

    Product Linagliptin Mix of form A & B

    DISCLAIMER

    The above product is presented solely for informational purposes and does not constitute an offer in any sense. Products with PIPELINE & EARLY DEVELOPMENT STATUS under patent (SPC) protection in Poland and/or other countries are not offered until expiration of the corresponding IP...
  • Pimavanserin tartrate Crystalline anhydrous form C

    Product Pimavanserin tartrate Crystalline anhydrous form C

    DISCLAIMER

    The above product is presented solely for informational purposes and does not constitute an offer in any sense. Products with PIPELINE & EARLY DEVELOPMENT STATUS under patent (SPC) protection in Poland and/or other countries are not offered until expiration of the corresponding IP...
  • Rivaroxaban

    Product Rivaroxaban

    DISCLAIMER

    The above product is presented solely for informational purposes and does not constitute an offer in any sense. Products with PIPELINE & EARLY DEVELOPMENT STATUS under patent (SPC) protection in Poland and/or other countries are not offered until expiration of the corresponding IP...
  • Sitagliptin hydrochloride Polymorphic form III

    Product Sitagliptin hydrochloride Polymorphic form III

    DISCLAIMER

    The above product is presented solely for informational purposes and does not constitute an offer in any sense. Products with PIPELINE & EARLY DEVELOPMENT STATUS under patent (SPC) protection in Poland and/or other countries are not offered until expiration of the corresponding IP...
  • Isavuconazole sulfate

    Product Isavuconazole sulfate

    DISCLAIMER

    The above product is presented solely for informational purposes and does not constitute an offer in any sense. Products with PIPELINE & EARLY DEVELOPMENT STATUS under patent (SPC) protection in Poland and/or other countries are not offered until expiration of the corresponding IP...
  • Enzalutamide

    Product Enzalutamide

     We provide with Anhydrous form R1

    Enzalutamide is a second-generation androgen receptor inhibitor used to treat castration-resistant prostate cancer and metastatic castration-sensitive prostate cancer. Enzalutamide is an androgen receptor (AR) inhibitor for the treatment of c...
  • Isavuconazole

    Product Isavuconazole

    under development
  • Sacubitril Valsartan

    Product Sacubitril Valsartan

    Crystalline polymorphic form
    Sacubitril/valsartan is the first agent to be approved in a new class of drugs called angiotensin receptor neprilysin inhibitor (ARNI). The medication is FDA-approved to treat patients with chronic heart failure with reduced ejection fraction (HFrEF) with NYHA class I...
  • Ticagrelor, Form II

    Product Ticagrelor, Form II

    DISCLAIMER Each product is protected by a patent in force in Poland and is therefore developed and manufactured solely for the purpose of Regulatory Submissions or R&D purposes. This product is not offered for sale in countries where the patent is valid and the offer or sale or any relat...